KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $3.9 million.

  • CareDx's Change in Accured Expenses fell 1837.38% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.3 million, marking a year-over-year decrease of 21745.15%. This contributed to the annual value of -$95.7 million for FY2024, which is 20675.5% down from last year.
  • Latest data reveals that CareDx reported Change in Accured Expenses of $3.9 million as of Q3 2025, which was down 1837.38% from $4.8 million recorded in Q2 2025.
  • CareDx's Change in Accured Expenses' 5-year high stood at $93.1 million during Q4 2023, with a 5-year trough of -$105.9 million in Q4 2024.
  • In the last 5 years, CareDx's Change in Accured Expenses had a median value of $2.4 million in 2023 and averaged $27684.2.
  • As far as peak fluctuations go, CareDx's Change in Accured Expenses soared by 222727.27% in 2021, and later tumbled by 39962.66% in 2025.
  • Quarter analysis of 5 years shows CareDx's Change in Accured Expenses stood at $3.0 million in 2021, then soared by 664.06% to $22.9 million in 2022, then surged by 305.76% to $93.1 million in 2023, then plummeted by 213.79% to -$105.9 million in 2024, then surged by 103.65% to $3.9 million in 2025.
  • Its Change in Accured Expenses stands at $3.9 million for Q3 2025, versus $4.8 million for Q2 2025 and -$24.1 million for Q1 2025.